Correlation between Selenium and Zinc Levels and Survival among Prostate Cancer Patients

The most prevalent type of cancer among males is prostate cancer. Survival is considered quite good, but it can be further improved when risk factors are optimized. One of these factors is micronutrients, including Se and Zn. To our knowledge, the interaction between Se and Zn and prostate cancer re...

Full description

Bibliographic Details
Main Authors: Sandra Pietrzak, Wojciech Marciniak, Róża Derkacz, Milena Matuszczak, Adam Kiljańczyk, Piotr Baszuk, Marta Bryśkiewicz, Andrzej Sikorski, Jacek Gronwald, Marcin Słojewski, Cezary Cybulski, Adam Gołąb, Tomasz Huzarski, Tadeusz Dębniak, Marcin R. Lener, Anna Jakubowska, Tomasz Kluz, Rodney J. Scott, Jan Lubiński
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/16/4/527
_version_ 1797297288800894976
author Sandra Pietrzak
Wojciech Marciniak
Róża Derkacz
Milena Matuszczak
Adam Kiljańczyk
Piotr Baszuk
Marta Bryśkiewicz
Andrzej Sikorski
Jacek Gronwald
Marcin Słojewski
Cezary Cybulski
Adam Gołąb
Tomasz Huzarski
Tadeusz Dębniak
Marcin R. Lener
Anna Jakubowska
Tomasz Kluz
Rodney J. Scott
Jan Lubiński
author_facet Sandra Pietrzak
Wojciech Marciniak
Róża Derkacz
Milena Matuszczak
Adam Kiljańczyk
Piotr Baszuk
Marta Bryśkiewicz
Andrzej Sikorski
Jacek Gronwald
Marcin Słojewski
Cezary Cybulski
Adam Gołąb
Tomasz Huzarski
Tadeusz Dębniak
Marcin R. Lener
Anna Jakubowska
Tomasz Kluz
Rodney J. Scott
Jan Lubiński
author_sort Sandra Pietrzak
collection DOAJ
description The most prevalent type of cancer among males is prostate cancer. Survival is considered quite good, but it can be further improved when risk factors are optimized. One of these factors is micronutrients, including Se and Zn. To our knowledge, the interaction between Se and Zn and prostate cancer remains undescribed. This study aimed to investigate the optimal levels of selenium (Se) and zinc (Zn) and their impact on the survival of individuals diagnosed with prostate cancer. A total of 338 prostate cancer patients were enrolled in this study, which was conducted in Poland between 2009 and 2015. Mass spectrometry, which uses inductively coupled plasma mass, was used to assess serum element levels before treatment. The study participants were categorized into quartiles (QI-QIV) based on the distributions of Se and Zn levels observed among surviving participants. Cox regression was used to assess the association between serum Se and Zn levels and the survival of prostate cancer patients. Our results reveal the effect of combined Se and Zn levels on survival in prostate cancer patients (SeQI-ZnQI vs. SeQIV-ZnQIV; HR = 20.9). These results need further research to establish Se/Zn norms for different populations.
first_indexed 2024-03-07T22:18:49Z
format Article
id doaj.art-b796bf90c35d45769fdf08f1b477e8e1
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-07T22:18:49Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-b796bf90c35d45769fdf08f1b477e8e12024-02-23T15:29:59ZengMDPI AGNutrients2072-66432024-02-0116452710.3390/nu16040527Correlation between Selenium and Zinc Levels and Survival among Prostate Cancer PatientsSandra Pietrzak0Wojciech Marciniak1Róża Derkacz2Milena Matuszczak3Adam Kiljańczyk4Piotr Baszuk5Marta Bryśkiewicz6Andrzej Sikorski7Jacek Gronwald8Marcin Słojewski9Cezary Cybulski10Adam Gołąb11Tomasz Huzarski12Tadeusz Dębniak13Marcin R. Lener14Anna Jakubowska15Tomasz Kluz16Rodney J. Scott17Jan Lubiński18Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, PolandRead-Gene, Grzepnica, ul. Alabastrowa 8, 72-003 Dobra, PolandRead-Gene, Grzepnica, ul. Alabastrowa 8, 72-003 Dobra, PolandDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, PolandDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, PolandDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, PolandDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, PolandDepartment of Urology and Urological Oncology, Pomeranian Medical University in Szczecin, al. Powstańców Wielkopolskich 72, 71-899 Szczecin, PolandDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, PolandDepartment of Urology and Urological Oncology, Pomeranian Medical University in Szczecin, al. Powstańców Wielkopolskich 72, 71-899 Szczecin, PolandDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, PolandDepartment of Urology and Urological Oncology, Pomeranian Medical University in Szczecin, al. Powstańców Wielkopolskich 72, 71-899 Szczecin, PolandDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, PolandDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, PolandDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, PolandDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, PolandDepartment of Gynecology, Gynecology Oncology and Obstetrics, Fryderyk Chopin University Hospital No. 1, 35-055 Rzeszow, PolandPriority Research Centre for Cancer Research, Innovation and Translation, Hunter Medical Research Institute, New Lambton, NSW 2305, AustraliaDepartment of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, ul. Unii Lubelskiej 1, 71-252 Szczecin, PolandThe most prevalent type of cancer among males is prostate cancer. Survival is considered quite good, but it can be further improved when risk factors are optimized. One of these factors is micronutrients, including Se and Zn. To our knowledge, the interaction between Se and Zn and prostate cancer remains undescribed. This study aimed to investigate the optimal levels of selenium (Se) and zinc (Zn) and their impact on the survival of individuals diagnosed with prostate cancer. A total of 338 prostate cancer patients were enrolled in this study, which was conducted in Poland between 2009 and 2015. Mass spectrometry, which uses inductively coupled plasma mass, was used to assess serum element levels before treatment. The study participants were categorized into quartiles (QI-QIV) based on the distributions of Se and Zn levels observed among surviving participants. Cox regression was used to assess the association between serum Se and Zn levels and the survival of prostate cancer patients. Our results reveal the effect of combined Se and Zn levels on survival in prostate cancer patients (SeQI-ZnQI vs. SeQIV-ZnQIV; HR = 20.9). These results need further research to establish Se/Zn norms for different populations.https://www.mdpi.com/2072-6643/16/4/527seleniumzincprostate cancersurvival
spellingShingle Sandra Pietrzak
Wojciech Marciniak
Róża Derkacz
Milena Matuszczak
Adam Kiljańczyk
Piotr Baszuk
Marta Bryśkiewicz
Andrzej Sikorski
Jacek Gronwald
Marcin Słojewski
Cezary Cybulski
Adam Gołąb
Tomasz Huzarski
Tadeusz Dębniak
Marcin R. Lener
Anna Jakubowska
Tomasz Kluz
Rodney J. Scott
Jan Lubiński
Correlation between Selenium and Zinc Levels and Survival among Prostate Cancer Patients
Nutrients
selenium
zinc
prostate cancer
survival
title Correlation between Selenium and Zinc Levels and Survival among Prostate Cancer Patients
title_full Correlation between Selenium and Zinc Levels and Survival among Prostate Cancer Patients
title_fullStr Correlation between Selenium and Zinc Levels and Survival among Prostate Cancer Patients
title_full_unstemmed Correlation between Selenium and Zinc Levels and Survival among Prostate Cancer Patients
title_short Correlation between Selenium and Zinc Levels and Survival among Prostate Cancer Patients
title_sort correlation between selenium and zinc levels and survival among prostate cancer patients
topic selenium
zinc
prostate cancer
survival
url https://www.mdpi.com/2072-6643/16/4/527
work_keys_str_mv AT sandrapietrzak correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT wojciechmarciniak correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT rozaderkacz correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT milenamatuszczak correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT adamkiljanczyk correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT piotrbaszuk correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT martabryskiewicz correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT andrzejsikorski correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT jacekgronwald correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT marcinsłojewski correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT cezarycybulski correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT adamgołab correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT tomaszhuzarski correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT tadeuszdebniak correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT marcinrlener correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT annajakubowska correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT tomaszkluz correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT rodneyjscott correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients
AT janlubinski correlationbetweenseleniumandzinclevelsandsurvivalamongprostatecancerpatients